• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[尖端扭转型室速综合征。变异与局限]

[Torsade de pointes syndromes. Variations and limits].

作者信息

Coumel P, Lucet V

出版信息

Ann Cardiol Angeiol (Paris). 1986 Apr;35(4):205-14.

PMID:3740773
Abstract

Advances in cardiac rhythm studies have led to more precise definitions of wave burst arrhythmias since they were first described by Dessertenne. This progress has also broadened the scope of these arrhythmias and the initially defined limits no longer apply. Prolonged Q-T syndromes, whether inherited or acquired, remain the standard, characterized by the ECG so typical of tachycardiac rhythms with long coupling of the initial extrasystole. In the congenital forms, neurogenic, sympathetic stimulation plays a triggering role, whereas sympathetic hypertonia of humoral origin protects acquired forms. Catecholaminergic ventricular tachycardia is clearly related to congenital Q-T syndrome and involves the same treatment, but tends to show idiosyncrasy to quinidine compounds, in common with acquired forms of Q-T syndrome. Short-coupling wave burst arrhythmias are congenital and in principle idiopathic. They have triggering factors in common with acquired prolonged Q-T syndromes, but their interactions with the autonomic nervous system are more complex; the vagus and sympathetic nerves are equally implicated and these interactions are curiously sensitive to calcium antagonists. These four related syndromes form an "ill-defined group" the limits of which will become clearer as more knowledge is acquired regarding the substrate and the interactions with the autonomic nervous system.

摘要

自从 Dessertenne 首次描述以来,心脏节律研究的进展已使对波群性心律失常有了更精确的定义。这一进展也拓宽了这些心律失常的范围,最初定义的界限已不再适用。无论是遗传性还是后天获得性的长 QT 综合征,仍然是标准情况,其心电图特征为心动过速节律且初始期前收缩的配对间期较长。在先天性形式中,神经源性、交感神经刺激起触发作用,而体液源性的交感神经张力亢进则保护后天获得性形式。儿茶酚胺能性室性心动过速与先天性 QT 综合征明显相关且治疗相同,但与后天获得性 QT 综合征一样,对奎尼丁类化合物往往表现出特异性。短配对波群性心律失常是先天性的,原则上是特发性的。它们与后天获得性长 QT 综合征有共同的触发因素,但它们与自主神经系统的相互作用更为复杂;迷走神经和交感神经均有涉及,且这些相互作用对钙拮抗剂异常敏感。这四种相关综合征构成一个“界限不明的组”,随着对其基质以及与自主神经系统相互作用的了解增多,其界限将变得更加清晰。

相似文献

1
[Torsade de pointes syndromes. Variations and limits].[尖端扭转型室速综合征。变异与局限]
Ann Cardiol Angeiol (Paris). 1986 Apr;35(4):205-14.
2
Torsade de pointes: the clinical considerations.尖端扭转型室性心动过速:临床考量
Int J Cardiol. 2004 Jul;96(1):1-6. doi: 10.1016/j.ijcard.2003.04.055.
3
Mechanisms and management of congenital and acquired long QT syndromes.先天性和获得性长QT综合征的机制与管理
Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:51-5.
4
The long Q-T interval and syndromes.长Q-T间期及综合征。
Adv Intern Med. 1987;32:87-110.
5
[The diagnostic value of standard ECG methods, the cold-pressure test and Valsalva maneuver in idiopathic QT syndrome].[标准心电图方法、冷压试验及瓦尔萨尔瓦动作在特发性QT综合征中的诊断价值]
Z Kardiol. 1993 Jan;82(1):1-7.
6
[Diastolic micropotentials in high-resolution surface ECG in QT syndrome].[QT综合征高分辨率体表心电图中的舒张期微电位]
Z Kardiol. 1986 Jul;75(7):410-6.
7
Congenital long QT syndrome.
Rev Cardiovasc Med. 2006 Summer;7(3):160-5.
8
Possible mechanisms of the arrhythmias in the long QT syndrome.
Eur Heart J. 1985 Nov;6 Suppl D:115-29. doi: 10.1093/eurheartj/6.suppl_d.115.
9
Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.在长QT综合征中,巨大T-U波先于尖端扭转型室速出现:对获得性和先天性QT延长患者的系统心电图分析。
J Am Coll Cardiol. 2009 Jul 7;54(2):143-9. doi: 10.1016/j.jacc.2009.03.043.
10
Polymorphous ventricular tachycardia associated with normal and long Q-T intervals.与正常及长Q-T间期相关的多形性室性心动过速
Am J Cardiol. 1982 Jun;49(8):2021-9. doi: 10.1016/0002-9149(82)90224-7.

引用本文的文献

1
Torsades de pointes, a quarter of a century later: a tribute to Dr. F. Dessertenne.
Cardiovasc Drugs Ther. 1991 Feb;5(1):167-9. doi: 10.1007/BF03029818.